ERIC SKOLNIK - 02 Dec 2022 Form 4 Insider Report for BLONDER TONGUE LABORATORIES INC (BDRL)

Role: Senior Vice President - CFO
Signature: /s/ Eric Skolnik
Issuer symbol: BDRL
Transactions as of: 02 Dec 2022
Net transactions value: +$529
Form type: 4
Filing time: 05 Dec 2022, 15:15:31 UTC
Previous filing: 21 Nov 2022
Next filing: 19 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDRL	Common Stock, par value $0.001	Award	$529	+2,518	+2.8%	$0.2100	93,118	02 Dec 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to a Deferred Compensation Agreement between the reporting person and the issuer, on the date on which a portion of the reporting person's compensation has been deferred, the issuer accrued the number of shares indicated. The number of shares of common stock accrued represents the quotient of (i) the portion of compensation deferred divided by (ii) the fair market value per share of the issuer's common stock on the indicated date (equal to the closing price reported on the OTCQB on such date). These shares will be delivered to the reporting person during the first quarter of 2024.

Content

Pursuant to a Deferred Compensation Agreement between the reporting person and the issuer, on the date on which a portion of the reporting person's compensation has been deferred, the issuer accrued the number of shares indicated. The number of shares of common stock accrued represents the quotient of (i) the portion of compensation deferred divided by (ii) the fair market value per share of the issuer's common stock on the indicated date (equal to the closing price reported on the OTCQB on such date). These shares will be delivered to the reporting person during the first quarter of 2024.